Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2006-8-7
pubmed:abstractText
This study aimed to prospectively identify the best single predictor and the best set of predictors of risk for nonadherence with anti-psychotic medication in the treatment of patients with schizophrenia.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0160-6689
pubmed:author
pubmed:issnType
Print
pubmed:volume
67
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1114-23
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:16889456-Administration, Oral, pubmed-meshheading:16889456-Adult, pubmed-meshheading:16889456-Antidepressive Agents, pubmed-meshheading:16889456-Antipsychotic Agents, pubmed-meshheading:16889456-Cognition Disorders, pubmed-meshheading:16889456-Drug Utilization, pubmed-meshheading:16889456-Female, pubmed-meshheading:16889456-Follow-Up Studies, pubmed-meshheading:16889456-Health Status, pubmed-meshheading:16889456-Humans, pubmed-meshheading:16889456-Longitudinal Studies, pubmed-meshheading:16889456-Male, pubmed-meshheading:16889456-Medical Records, pubmed-meshheading:16889456-Prospective Studies, pubmed-meshheading:16889456-Psychiatric Status Rating Scales, pubmed-meshheading:16889456-Risk Factors, pubmed-meshheading:16889456-Schizophrenia, pubmed-meshheading:16889456-Schizophrenic Psychology, pubmed-meshheading:16889456-Treatment Refusal, pubmed-meshheading:16889456-United States
pubmed:year
2006
pubmed:articleTitle
A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia.
pubmed:affiliation
Eli Lilly and Co., Lilly Corporate Center, Indianapolis, IN 46285, USA. haya@lilly.com
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Research Support, Non-U.S. Gov't, Multicenter Study